Thomas Schinecker, future Roche CEO
July 21, 2022 12:28 PM EDTUpdated 01:20 PM
Bioregnum

The new CEO at Roche has fol­lowed a fa­mil­iar path in­to the C-suite. But it's his next steps that are cru­cial to his suc­cess

Af­ter Sev­erin Schwan got the nod as the new CEO of Roche, it es­caped no one’s at­ten­tion that he had been steeped in Basel cor­po­rate …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

A service from the Financial Times